
Cyprus remains heavily reliant on imported medicines, with only around 40 per cent of authorised pharmaceutical products actually available on the island, according to a European Commission staff working document on the EU’s pharmaceutical strategy .
The same report notes that approximately 20 per cent of medicines in Cyprus are imported under Article 5 of Directive 2001/83/EC, which permits supply without marketing authorisation in cases of special medical need.
The